We are live on
!
Find out more
CI
Clal Insurance Portfolio holdings
AUM
$22.3B
1-Year Est. Return
79.91%
This Fund
S&P 500
This Quarter
Est. Return
+1.91%
1 Year Est. Return
+79.91%
3 Year Est. Return
+201.85%
5 Year Est. Return
+220.25%
10 Year Est. Return
+954.66%
AUM
$3.76B
AUM Growth
-$34.7M
(-0.91%)
Cap. Flow
-$64.8M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
65.5%
Holding
82
New
17
Increased
17
Reduced
20
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$123M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$68.1M |
| 3 |
Perrigo
PRGO
|
+$46M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$42.5M |
| 5 |
The Mosaic Company
MOS
|
+$36.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$130M |
| 2 |
iShares US Pharmaceuticals ETF
IHE
|
+$116M |
| 3 |
Viatris
VTRS
|
+$60.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$40.7M |
| 5 |
XYZ
Block Inc
XYZ
|
+$37.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.79% |
| 2 | Technology | 16.53% |
| 3 | Financials | 6.72% |
| 4 | Industrials | 5.99% |
| 5 | Healthcare | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard S&P 500 ETF
VOO
$1.04T
| $629M | 16.71% |
2,598,115
+271,435
| +12% | +$68.1M |
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$803B
| $429M | 11.39% |
1,623,097
-149,139
| -8% | -$40.7M |
|
3
State Street Financial Select Sector SPDR ETF
XLF
$54.5B
| $353M | 9.37% |
12,791,417
-510,681
| -4% | -$14.7M |
|
4
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$710M
| $176M | 4.67% |
4,147,669
+381,571
| +10% | +$16.6M |
|
|
5
Perrigo
PRGO
$1.89B
| $164M | 4.35% |
1,963,646
+527,025
| +37% | +$46M |
|
6
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $161M | 4.27% |
2,749,052
-101,546
| -4% | -$6.01M |
|
|
ORBK
7
DELISTED
Orbotech Ltd
ORBK
| $152M | 4.03% |
2,441,696
+102,079
| +4% | +$5.6M |
|
8
WisdomTree India Earnings Fund ETF
EPI
$1.99B
| $136M | 3.61% |
5,187,486
+6,780
| +0.1% | +$186K |
|
|
MLNX
9
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $135M | 3.59% |
1,852,023
+631,345
| +52% | +$42.5M |
|
|
XYZ
10
Block Inc
XYZ
$47.8B
| $132M | 3.5% |
2,679,716
-820,284
| -23% | -$37.6M |
|
11
Ormat Technologies
ORA
$5.66B
| $126M | 3.35% |
2,236,806
+258,900
| +13% | +$16.1M |
|
|
12
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| $119M | 3.15% |
+1,352,197
| New | +$123M |
|
|
BID
13
DELISTED
Sotheby's
BID
| $100M | 2.66% |
1,950,000
+350,000
| +22% | +$17.8M |
|
14
Meta Platforms (Facebook)
META
$1.7T
| $96M | 2.55% |
600,501
-16,200
| -3% | -$2.91M |
|
|
15
iShares Biotechnology ETF
IBB
$10.4B
| $78.8M | 2.1% |
738,534
-1,169,091
| -61% | -$130M |
|
16
AerCap
AER
$22.2B
| $75M | 1.99% |
1,478,000
+178,000
| +14% | +$9.23M |
|
17
Mastercard
MA
$503B
| $74M | 1.97% |
422,618
-129,971
| -24% | -$22.2M |
|
18
Visa
V
$701B
| $73.5M | 1.95% |
614,560
-69,162
| -10% | -$8.38M |
|
19
Alphabet (Google) Class A
GOOGL
$4.27T
| $51.8M | 1.38% |
998,040
-301,960
| -23% | -$16.7M |
|
20
Bank of America
BAC
$416B
| $51.7M | 1.37% |
1,725,000
-75,000
| -4% | -$2.36M |
|
21
PayPal
PYPL
$46.2B
| $51.1M | 1.36% |
673,694
-156,306
| -19% | -$12.4M |
|
22
SolarEdge
SEDG
$2.17B
| $40.5M | 1.08% |
770,549
+767,826
| +28,198% | +$33.7M |
|
23
Live Nation Entertainment
LYV
$39.6B
| $37.9M | 1.01% |
900,000
+200,000
| +29% | +$8.87M |
|
24
Tower Semiconductor
TSEM
$21.6B
| $34.9M | 0.93% |
1,296,520
+385,000
| +42% | +$12.3M |
|
|
25
The Mosaic Company
MOS
$8.01B
| $34M | 0.9% |
+1,400,000
| New | +$36.8M |
|
Similar funds
LF
DCP
CS
CIG
TAF
SOMRS
MIM
Clal Insurance's Q1 2018 Portfolio in Review
As of Q1 2018, Clal Insurance held 82 positions worth $3.76B, down 0.91% from $3.8B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Clal Insurance's Q1 2018 filing shows 17 new, 17 increased, 20 reduced and 9 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,352,197 shares worth $119M. The largest sale was iShares Biotechnology ETF, an estimated $130M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 59% a quarter earlier, followed by Technology and Financials.
- Clal Insurance's largest Q1 2018 buy was State Street SPDR S&P Biotech ETF: 1,352,197 shares worth $119M.
- Clal Insurance added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $68.1M increase.
- Clal Insurance's biggest Q1 2018 reduction was iShares Biotechnology ETF, cutting an estimated $130M.
- Clal Insurance fully exited iShares US Pharmaceuticals ETF in Q1 2018, selling an estimated $116M.
- Clal Insurance's ten largest holdings make up 66% of its $3.76B portfolio in Q1 2018.
- Clal Insurance opened 17 new positions and closed 9 in Q1 2018.
- Clal Insurance's portfolio value fell 0.91% quarter-over-quarter to $3.76B.
Based on Clal Insurance's 13F filing for Q1 2018, filed 2 May 2018.